Hydroxocobalamin for vasoplegia in cardiac surgery: a retrospective cohort analysis
British Journal of Anaesthesia · 2025-10 · 135 (4) · 870-877
DOI: 10.1016/j.bja.2025.05.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Anaesthesia, 2025-10. Verfasst von Luai Zakaria und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Anesthesiology, Integrated Hospital-Care Institute, Cleveland Clinic, Cleveland, OH, USA; Outcomes Research Consortium, …. Hauptthemen laut MEDLINE: Vasoplegia, Hydroxocobalamin, Cardiac Surgical Procedures. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Vasoplegia during cardiac surgery is common and associated with perioperative mortality. Hydroxocobalamin is a catecholamine-sparing approach for treating vasoplegia. However, there is currently limited evidence to inform its use. METHODS: We conducted a single-centre retrospective propensity-matched cohort study of patients who developed vasoplegia after cardiopulmonary bypass. Our primary outcome was vasopressor requirement, expressed as norepinephrine equivalents (NEE), at 1, 4, 24, and 48 h after treatment. Our secondary outcome was a collapsed composite of in-hospital complications comprising stroke, sternal wound infection, mesenteric ischaemia, renal failure, and death. RESULTS: We identified 2727 (11%) patients with vasoplegia from 2018 to 2024. The final analysis cohort included 229 matched pairs. Hydroxocobalamin administration was associated with a significant reduction in median NEE infusion rates of -0.04 (95% confidence interval [CI]: -0.07 to -0.02; P=0.008) μg kg-1 min-1 at 1 h, -0.05 (95% CI: -0.07 to -0.02; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Anesthesiology, Integrated Hospital-Care Institute, Cleveland Clinic, Cleveland, OH, USA; Outcomes Research Consortium, Houston, TX, USA. Electronic address: ZakariL@ccf.org.
- Outcomes Research Consortium, Houston, TX, USA; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
- Outcomes Research Consortium, Houston, TX, USA.
- Department of Cardiothoracic Anesthesiology, Integrated Hospital-Care Institute, Cleveland Clinic, Cleveland, OH, USA; Outcomes Research Consortium, Houston, TX, USA.
- Department of Cardiovascular Surgery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
- Outcomes Research Consortium, Houston, TX, USA; Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest School of Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Zitieren
APA
Zakaria, L., Shah, K., Yang, D., Kelava, M., Elgharably, H., Khanna, A. K., Ahuja, S., Hohlfelder, B., Alfirevic, A., Duncan, A. E., Skubas, N. J., & Sessler, D. I. (2025). Hydroxocobalamin for vasoplegia in cardiac surgery: a retrospective cohort analysis. British Journal of Anaesthesia, 135(4), 870-877. https://doi.org/10.1016/j.bja.2025.05.026
Vancouver
Zakaria L, Shah K, Yang D, Kelava M, Elgharably H, Khanna AK, et al. Hydroxocobalamin for vasoplegia in cardiac surgery: a retrospective cohort analysis. British Journal of Anaesthesia. 2025;135(4):870-877. doi:10.1016/j.bja.2025.05.026
BibTeX
@article{Zakaria2025,
author = {Zakaria, Luai and Shah, Karan and Yang, Dongsheng and Kelava, Marta and Elgharably, Haytham and Khanna, Ashish K and Ahuja, Sanchit and Hohlfelder, Benjamin and Alfirevic, Andrej and Duncan, Andra E and Skubas, Nikolaos J and Sessler, Daniel I},
title = {Hydroxocobalamin for vasoplegia in cardiac surgery: a retrospective cohort analysis},
journal = {British Journal of Anaesthesia},
year = {2025},
volume = {135},
number = {4},
pages = {870--877},
doi = {10.1016/j.bja.2025.05.026}
}
EUVIMED